01 April 2026
The Welsh Medicines Advice Service (WMAS) joined the All Wales Therapeutics and Toxicology Centre (AWTTC) on 1 April 2026, marking an important step in strengthening medicines information and advisory services across NHS Wales.
WMAS is part of the UK Medicines Information (UKMi) network, an NHS pharmacy-based service dedicated to supporting the safe, effective and efficient use of medicines. It provides evidence-based information and expert advice on the therapeutic use of medicines to healthcare professionals.
In addition to the enquiry answering service, WMAS hosts the UK Porphyria Medicines Information Service (UKPMIS) which supports healthcare professionals and patients across the UK providing specialist advice on the use of drugs in acute porphyrias. The porphyria specialist pharmacists are members of the International Porphyria Network (Ipnet) working group which assesses unclassified drugs for inclusion in the international Acute Porphyria database (hosted by NAPOS, the Norwegian porphyria centre). WMAS works closely with Yellow Card Centre Wales to support medicines safety and pharmacovigilance.
By joining AWTTC, WMAS will further enhance collaboration at a national level, supporting consistent, high-quality medicines advice across Wales. The integration will strengthen links between the two organisations helping to ensure patients receive the most appropriate and evidence-based treatments.
The move reflects ongoing efforts within NHS Wales to improve access to specialist knowledge, ultimately supporting better outcomes for patients and more effective use of healthcare resources.